BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (“AVI”), a medical device company specializing in developing advanced vascular access solutions, and Medline, the largest provider of medical-surgical products and supply chain solutions serving all points of care, today announced a multi-year agreement to accelerate the rollout of AVI’s next-generation catheters, HydroMID® and HydroPICC®, which recently received an anti-thrombogenic indication from the FDA. The initiative bolsters Medlin
Author: Ken Dropiewski
PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports
MIAMI, June 22, 2026 /PRNewswire/ — PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the FLEXI-PORT™ family of implantable vascular access ports….
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change
Platform Expected to Target Expansion into Multi-Billion-Dollar Cardiovascular Market with Potential Class II Diagnostic Regulatory Path
GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage
AI-Powered Triage Software Helps Radiologists Identify and Prioritize Peripheral Vascular Disease in Lower-Extremity CT Imaging AI-Powered Triage Software Helps Radiologists Identify and Prioritize Peripheral Vascular Disease in Lower-Extremity CT Imaging
Route 92 Medical Announces First Commercial Cases in Canada
Route 92 Medical announces first commercial cases in Canada following Health Canada Medical Device license for advanced neurovascular portfolio.
TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke
TETmedical, Inc. a clinical stage medical diagnostic company received FDA breakthrough technology designation for its NSE-Functional Activity Stroke Test
Murj® Expands Global Footprint with Commercial Launch in Australia and New Zealand
SYDNEY and AUCKLAND, New Zealand, June 21, 2026 /PRNewswire/ — Murj®, a cardiac device management software company, today announced its official expansion into the Australian market alongside broader availability for New Zealand. Following its exhibition at the recent CSANZ / HRS…
Nyra Medical Receives Prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at EuroPCR 2026
ATLANTA, June 18, 2026 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, today announced that it has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for Cardiovascular Innovation, presented during EuroPCR 2026, the world’s leading…
AHN’s Allegheny General Hospital Unveils New, State-of-the-Art Cardiac Cath and Electrophysiology Labs, following Completion of $19 Million Renovation Project
New Cardiac Unit Supports Innovative New Procedures, Including Pulsed Field Ablation for Heart Rhythm Disorders PITTSBURGH, June 18, 2026 /PRNewswire/ — Allegheny Health Network’s (AHN) Allegheny General Hospital (AGH) today announced completion of a $19 million renovation and expansion…
egnite Expands Medical Advisory Board with Three Nationally Recognized Cardiovascular Specialists
New appointments add structural heart, cardiothoracic surgery, and real-world outcomes expertise to advance egnite’s cardiovascular intelligence platform ALISO VIEJO, Calif., June 18, 2026 /PRNewswire/ — egnite, Inc., a healthcare AI company focused on helping clinicians identify and…



